Schedule 13D ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: 2018-01-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,901,295
Percent of class
10.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000109
Form type
SC 13D/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Feb 07, 2018
Reporting period
Jan 24, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub